Formerly About Advanced Micro Devices Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Road Walker who wrote (531914)	11/23/2009 1:58:43 PM
From: i-node	Read Replies (3) of 1575342

So do private insurance companies pay for that drug for liver cancer patients to the tune of $400K to extend their lives by 2 months? It doesn't work like the show suggested at all. Medicare is not allowed to consider the cost of a medication in determining whether to pay for it; the decision is based on effectiveness, NOT "cost-effectiveness". The "2 months" claim is utter nonsense. Claims of averages like this are totally meaningless and misleading when you're dealing with cancer treatments. On average, treatment with Taxol or Tamoxifen would not be justifiable. But when a tumor is hormone-sensitive, these are highly effective treatments. The "average of 2 months" or for Avastin, "5 months", is bullshit. If you can determine the tumor is responsive to Avastin, it may extend life by several years.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next